Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Psychopharmacology|May 8, 2014
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypesBruce E Blough, Antonio Landavazo, Ann M Decker, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2011
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratMichael H Baumann, Robert D Clark, William L Woolverton, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.
Synapse (New York, N.Y.)|September 16, 2010
Evidence for noncompetitive modulation of substrate-induced serotonin releaseRichard B Rothman, Michael H Baumann, Bruce E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2006
Interaction of amphetamines and related compounds at the vesicular monoamine transporterJohn S Partilla, Allison G Dempsey, Ameet S Nagpal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')Michael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinansSubramaniam Ananthan, Naveen K Khare, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporterDavid Lewis, Ying Zhang, Thomas Prisinzano, et al.
European Journal of Medicinal Chemistry|July 25, 2013
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylationHwan Jung Lim, Christina M Dersch, Richard B Rothman, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Psychopharmacology|May 8, 2014
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypesBruce E Blough, Antonio Landavazo, Ann M Decker, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2011
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratMichael H Baumann, Robert D Clark, William L Woolverton, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.
Synapse (New York, N.Y.)|September 16, 2010
Evidence for noncompetitive modulation of substrate-induced serotonin releaseRichard B Rothman, Michael H Baumann, Bruce E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2006
Interaction of amphetamines and related compounds at the vesicular monoamine transporterJohn S Partilla, Allison G Dempsey, Ameet S Nagpal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')Michael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinansSubramaniam Ananthan, Naveen K Khare, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporterDavid Lewis, Ying Zhang, Thomas Prisinzano, et al.
European Journal of Medicinal Chemistry|July 25, 2013
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylationHwan Jung Lim, Christina M Dersch, Richard B Rothman, et al.
Pageof 16